Clinical News: Page 32

Medtronic recalls embolization device used to treat aneurysms
By AuntMinnie.com staff writers
The U.S. FDA announced that Medtronic has recalled its Pipeline Vantage 027 embolization device used to treat brain aneurysms.
March 20, 2025
Brain
2021 LCS guidelines increased uptake, but disparities persist
By Kate Madden Yee
Updated guidelines for lung cancer screening from the USPSTF in 2021 increased adherence, but disparities persist among particular patient populations.
March 20, 2025
Lung Ct Images
MRI identifies parts of the brain that remember words
By Kate Madden Yee
MRI has identified parts of the brain needed to remember words -- and how those parts may be affected by epilepsy.
March 19, 2025
Brain Puzzle Dementia
Osteoporosis risk assessment tools underperform in younger women
By Will Morton
Three screening tools recommended by the U.S. Preventive Services Task Force (USPSTF) are suboptimal for identifying women who may be at risk for osteoporosis.
March 19, 2025
Bmd
ASTRO vice chair highlights momentum for ROCR Act
By Amerigo Allegretto
Chris Corso, MD, PhD, from ASTRO discusses why the ROCR Act is needed to stabilize reimbursement for radiation oncologists in the U.S.
March 19, 2025
Radiation Therapy Suite 400
Adherence to LCS decreases after baseline screening
By Kate Madden Yee
Adherence to lung cancer screening (LCS) with low-dose CT (LDCT) decreases after baseline imaging, according to a new study.
March 19, 2025
Cancer Lung
Do radiologists trust mammography AI software?
By Erik L. Ridley
A large-scale prospective trial exploring the use of mammography AI software in a breast cancer screening program has found that recalls were lower when cases were flagged by AI.
March 18, 2025
Full-field digital screening mammograms in participants recalled by the consensus discussion after being flagged by artificial intelligence (AI) computer-aided detection (CAD) but not by either of the two radiologists. (A) Mammogram with AI CAD score of 73 for a 55-year-old woman diagnosed with grade 3 in situ cancer and T1 (9-mm) invasive cancer in the left breast and lymph node metastasis. (B) Mammogram with AI CAD score of 54 for a 49-year-old woman diagnosed with grade 2 in situ cancer and T1 (6-mm) invasive cancer in the right breast and without lymph node metastasis. All images and caption courtesy of the RSNA.
PCCT proves effective for estimating liver fat fraction
By Kate Madden Yee
Photon-counting CT (PCCT) is effective and accurate for estimating liver fat fraction.
March 18, 2025
Liver
Platelet function tests can improve outcomes for brain aneurysm patients
By Will Morton
Testing patients for how they respond to blood thinners before undergoing treatments for brain aneurysms can reduce their chances of subsequent stroke.
March 18, 2025
Aneurysm
IAEA touts radionuclide development activities
By Will Morton
The IAEA has highlighted its worldwide activities to meet increasing demands for alpha-emitting radionuclides for use in Targeted Alpha Therapy.
March 18, 2025
Isotopes1
FAPI-PET superior to FDG-PET for detecting bone cancer
By Will Morton
PET/CT imaging with fibroblast activation protein inhibitor (FAPI) detects more bone metastases than FDG-PET/CT in patients with different types of cancer.
March 17, 2025
Cancer Cell Target2
AIUM president previews annual conference
By Amerigo Allegretto
Health in outer space, emerging technologies, and fellowship are a few things that attendees can look forward to at the 2025 AIUM annual conference.
March 17, 2025
Ultrasound Probe Vascular 400
Previous Page
Page 32 of 3660
Next Page